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440 PRELIMINARY NOTES 
This sequence is similar to that  proposed for the metabolism of itaconate by liver 
mitochondria a but differs from that  suggested for itaconate utilization by  another 
pseudomonad 4. 
Investigations into the nature of enzyme D, which is believed to catalyse the 
direct formation of itaconyl-CoA from itaconate, ATP and CoA, and into the pro- 
perties of the enzymes here reported, are continuing. 
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Some observations on the lactate dehydrogenase of human neoplasic tissue 
The electrophoretic heterogeniety of lactate dehydrogenase (L-lactate: NAD oxido- 
reductase, EC 1.1.1.27) has been well documented 1-5. Although various workers use 
different methods for isolating the active components, it is generally agreed that  
five isoenzymes of lactate dehydrogenase can be demonstrated in mammalian tissues. 
The enzyme electrophoretic pat tern obtained from a given tissue appears to be 
specific for that  tissue with respect to the lactate dehydrogenase isoenzymes.  The 
data of PFLEIDERER, AND WACHSMUTH 6 indicate that  human fetal tissues demonstrate 
considerable similarity in their isoenzymic components. Tissue lactate dehydrogenase 
undergoes a differentiation process prenatally and during the early post-partum 
period, finally emerging as the adult- type pat tern with multible fractions. This 
communication compares normal adult tissue lactate dehydrogenase with that  obtained 
from neoplastic tissue and describes an apparent de-differentiation of theenzyme in 
malignant disease. 
Specimens were obtained at autopsy no later than 4 h post-mortem and rapidly 
frozen. The tissue was washed once in ice water and then repeatedly in cold saline to 
remove the majori ty of contaminating erythrocytes, and subsequently homogenized 
in ice cold 0.02 M veronal buffer (pH 8.6). Supernatant fractions for analysis were 
obtained after centrifuging at 2000 × g for 0. 5 h. 
The isoenzymes of lactate dehydrogenase were obtained using a Beckman- 
Spinco continuous--flow electrophoresis cell, assembled in a cold room, thus main- 
taining temperatures of less than IO ° across the paper curtain. 32 fractions were 
obtained for analysis. The reaction mixtures contained 2.5 ml of a fraction, 60 m M  
sodium L-lactate and 0.94 m M  NAD in a total  volume of 3 ml. The reaction was 
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followed at 34o m# in a Beckman DU spectrophotometer at I-min intervals for 5 min. 
Percent enzyme activity in the fractions were determined by planimetric analysis. 
The results obtained with normal and neoplastic tissue are described in Table I. 
In contrast to the diverse isoenzymic pattern of lactate dehydrogenase observed 
in normal tissue, neoplastic tissue appears to have lost this differentiation to a high 
T A B L E  I 
RACTATE DEHYDROGENASE PATTERNS OBSERVED IN NORMAL 
AND NEOPLASTIC TISSUE 
Number 
Specimen of 
samples V I V  I I I  [ 
Percent activity in fractions 
I I  
C a r d i a c  m u s c l e  3 0.2 3.0 i 1.9 27.8 5 ~}-8 
S k e l e t a l  m u s c l e  2 33.2 30.0 34.1 2.0 t .o 
Liver 4 54.0 14.8 17.2 8.0 5-7 
L u n g  4 0. 3 22.2 46.1 22.9 8.6 
Kidney 3 {).7 12.4 3 ° .1  27.9 28.{} 
Spleen 5 0.5 x8.4 50.5 20.7 9.9 
T e s t e s  2 0.2 31.2 43-7 20.2 4-5 
Erythrocytes  8 i .{} 30.9 4o.4 2{,.t~ 
L e u c o c y t e s  8 i 1.8 76. I {). 1 
1 I OO -- 
2 18. 7 30.9 42.7 
2 16.2 75.4 8-4 
2 1.3 72.9 19.2 0.7 
4 - - i o o  
1 1.6 21. 7 44.3 I8 .6  14.o 
2 I.O 4"5 86.2 8.1 " 
3 12.(3 82.8 4.6 --- 
2 10 '3 85"2 4.5 
4 lOO 
4 -- lOO 
M e l a n o b l a s t o m a  ( lung)  
A d e n o c a r c i n o m a  ( lung)  
S q u a m o u s  cell c a r c i n o m a  ( lung)  
S e m i n o m a  
P l a s m a c y t o m a  
Liver infiltrate ( a c u t e  g r a n u l o c y t i c  l e u k e m i a )  
Liver (metastases from l ung ,  p r i m a r y )  
Erythrocytes  ( e r y t h r o l e u k e m i a )  
Spleen ( a c u t e  g r a n u l o c y t i c  l e u k e m i a )  
L e u c o c y t e s  ( a c u t e  g r a n u l o c y t i c  l e u k e m i a )  
L e u c o c y t e s  ( c h r o n i c  l y m p h o c y t i c  l e u k e m i a )  
degree, the majority of activity now appearing in Fraction III. Those tissue homo- 
genates containing all of  the lactate dehydrogenase in Fraction III were concentrated 
in an effort to detect other areas of  activity. These experiments were uniformly 
negative indicating that the other 4 fractions were probably absent. 
T A B L E  I I  
ACTIVITY PERCENTAGE PATTERN AND MICHAELIS CONSTANTS FOR LACTATE ACID 
OBSERVED IN A MALIGNANT NEOPLASM METASTATIC TO LIVER, ADJACENT AND 
NON-NEOPLASTIC TISSUE, AND DISTANT NORMAL LIVER 
Percent activity 
l l I  I I  
Specimen 
V I V  1 
M a l i g n a n t  t i s s u e  i .o 4-5 8(}.2 8. t 
A d j a c e n t  non-neoplastic tissue 14. 3 20.2 48. i 14. i 3.3 
Distant normal liver 56.0 i6 .  t I9 .2  7.1 i .( i  
K m for lactate acid acid (raM) 
M a l i g n a n t  t i s s u e  6.0 l o 3.2 
A d j a c e n t  non-neoplastic tissue 7.2 7.0 8. i 3.0 t .4  
Distant normal liver 7.o 6. i 3-9 2.0 1.6 
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Histological sections of the malignancies that displayed multiple lactate dehy- 
drogenase fractions demonstrated surrounding non-neoplastic tissue. The activity 
patterns in these instances could in no way be correlated with the patterns of normal 
tissue indicating a loss of specificity possibly due to the adjacent tumor. The data 
in Table II summarizes results obtained when a nodule, metastatic to liver, an area 
adjacent to this neoplastic tissue and a section of liver far removed from the tumor 
were analyzed for lactate dehydrogenase isoenzymes. These results indicate that non- 
neoplastic tissue immediately surrounding the tumor has lost the pattern specificity 
of the parent tissue while an area not involved has retained the normal pattern. 
The Michaelis constants for lactate acid indicate subtle differences between each 
of the five isoenzymes in normal tissue (Table III). The tumor enzyme appears 
T A B L E  l l I  
M I C H A E L I S  C O N S T A N T S  F O R  L A C T A T E  A C I D  O B S E R V E D  I N  N O R M A L  
A N D  N E O P L A D T I C  T I S S U E  
K m ( m M )  
Specimen . . . . . . . .  
V I V  I I I  I I  I 
S k e l e t a l  m u s c l e  7-3 5 .6 3 .0 1.9 
L i v e r  8. 4 6.0 3.8 2.3 
H e a r t  - -~  3 . 4  2 . o  i .  i 
S p l e e n  - -  5-7 3-3 2.2 1.3 
S e m i n o m a  .... 7- I i i .  2 4.1 2.o 
M e l a n o b l a s t o m a  ( lung)  - -  12.2 
L e u c o c y t e s - ( g r a n u l , ~ v t i c  l e u k e m i a )  - -  lO. 5 - -  
similar to Fraction V in this respect but has the electrophoretic mobility of Fraction III. 
In summary, tumor lactate dehydrogenase has lost the high degree of hetero- 
geneity observed in normal human tissue, and the data suggests that Fraction III  
associated with neoplastic tissue may represent a structurally different protein 
characteristic of neoplastic tissue. Further investigations are currently being under- 
taken to elucidate more precisely the nature of tumor lactate dehydrogenase. 
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